288330 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Bridge Biotherapeutics, Inc. engages in the provision of manufacturing of pharmaceutical products. It also engages in the provision pharmacy research, development, and experimentation of medicines. The company was founded by Jeong-Gyu, Lee on September 17, 2015 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
288330 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company